MicroRNAs in Atrial Fibrillation

Birney, E.; Stamatoyannopoulos, J.A.; Dutta, A.; Guigó, R.; Gingeras, T.R.; Margulies, E.H.; Weng, Z.; Snyder, M.; Dermitzakis, E.T.; Thurman, R.E.; Kuehn, M.S.; Taylor, C.M.; Neph, S.; Koch, C.M.; Asthana, S.; Malhotra, A.; Adzhubei, I.; Greenbaum, J.A.; Andrews, R.M.; Flicek, P.; Boyle, P.J.; Cao, H.; Carter, N.P.; Clelland, G.K.; Davis, S.; Day, N.; Dhami, P.; Dillon, S.C.; Dorschner, M.O.; Fiegler, H.; Giresi, P.G.; Goldy, J.; Hawrylycz, M.; Haydock, A.; Humbert, R.; James, K.D.; Johnson, B.E.; Johnson, E.M.; Frum, T.T.; Rosenzweig, E.R.; Karnani, N.; Lee, K.; Lefebvre, G.C.; Navas, P.A.; Neri, F.; Parker, S.C.; Sabo, P.J.; Sandstrom, R.; Shafer, A.; Vetrie, D.; Weaver, M.; Wilcox, S.; Yu, M.; Collins, F.S.; Dekker, J.; Lieb, J.D.; Tullius, T.D.; Crawford, G.E.; Sunyaev, S.; Noble, W.S.; Dunham, I.; Denoeud, F.; Reymond, A.; Kapranov, P.; Rozowsky, J.; Zheng, D.; Castelo, R.; Frankish, A.; Harrow, J.; Ghosh, S.; Sandelin, A.; Hofacker, I.L.; Baertsch, R.; Keefe, D.; Dike, S.; Cheng, J.; Hirsch, H.A.; Sekinger, E.A.; Lagarde, J.; Abril, J.F.; Shahab, A.; Flamm, C.; Fried, C.; Hackermüller, J.; Hertel, J.; Lindemeyer, M.; Missal, K.; Tanzer, A.; Washietl, S.; Korbel, J.; Emanuelsson, O.; Pedersen, J.S.; Holroyd, N.; Taylor, R.; Swarbreck, D.; Matthews, N.; Dickson, M.C.; Thomas, D.J.; Weirauch, M.T.; Gilbert, J.; Drenkow, J.; Bell, I.; Zhao, X.; Srinivasan, K.G.; Sung, W.K.; Ooi, H.S.; Chiu, K.P.; Foissac, S.; Alioto, T.; Brent, M.; Pachter, L.; Tress, M.L.; Valencia, A.; Choo, S.W.; Choo, C.Y.; Ucla, C.; Manzano, C.; Wyss, C.; Cheung, E.; Clark, T.G.; Brown, J.B.; Ganesh, M.; Patel, S.; Tammana, H.; Chrast, J.; Henrichsen, C.N.; Kai, C.; Kawai, J.; Nagalakshmi, U.; Wu, J.; Lian, Z.; Lian, J.; Newburger, P.; Zhang, X.; Bickel, P.; Mattick, J.S.; Carninci, P.; Hayashizaki, Y.; Weissman, S.; Hubbard, T.; Myers, R.M.; Rogers, J.; Stadler, P.F.; Lowe, T.M.; Wei, C.L.; Ruan, Y.; Struhl, K.; Gerstein, M.; Antonarakis, S.E.; Fu, Y.; Green, E.D.; Karaöz, U.; Siepel, A.; Taylor, J.; Liefer, L.A.; Wetterstrand, K.A.; Good, P.J.; Feingold, E.A.; Guyer, M.S.; Cooper, G.M.; Asimenos, G.; Dewey, C.N.; Hou, M.; Nikolaev, S.; Montoya-Burgos, J.I.; Löytynoja, A.; Whelan, S.; Pardi, F.; Massingham, T.; Huang, H.; Zhang, N.R.; Holmes, I.; Mullikin, J.C.; Ureta-Vidal, A.; Paten, B.; Seringhaus, M.; Church, D.; Rosenbloom, K.; Kent, W.J.; Stone, E.A.; Batzoglou, S.; Goldman, N.; Hardison, R.C.; Haussler, D.; Miller, W.; Sidow, A.; Trinklein, N.D.; Zhang, Z.D.; Barrera, L.; Stuart, R.; King, D.C.; Ameur, A.; Enroth, S.; Bieda, M.C.; Kim, J.; Bhinge, A.A.; Jiang, N.; Liu, J.; Yao, F.; Vega, V.B.; Lee, C.W.; Ng, P.; Shahab, A.; Yang, A.; Moqtaderi, Z.; Zhu, Z.; Xu, X.; Squazzo, S.; Oberley, M.J.; Inman, D.; Singer, M.A.; Richmond, T.A.; Munn, K.J.; Rada-Iglesias, A.; Wallerman, O.; Komorowski, J.; Fowler, J.C.; Couttet, P.; Bruce, A.W.; Dovey, O.M.; Ellis, P.D.; Langford, C.F.; Nix, D.A.; Euskirchen, G.; Hartman, S.; Urban, A.E.; Kraus, P.; Van Calcar, S.; Heintzman, N.; Kim, T.H.; Wang, K.; Qu, C.; Hon, G.; Luna, R.; Glass, C.K.; Rosenfeld, M.G.; Aldred, S.F.; Cooper, S.J.; Halees, A.; Lin, J.M.; Shulha, H.P.; Zhang, X.; Xu, M.; Haidar, J.N.; Yu, Y.; Ruan, Y.; Iyer, V.R.; Green, R.D.; Wadelius, C.; Farnham, P.J.; Ren, B.; Harte, R.A.; Hinrichs, A.S.; Trumbower, H.; Clawson, H.; Hillman-Jackson, J.; Zweig, A.S.; Smith, K.; Thakkapallayil, A.; Barber, G.; Kuhn, R.M.; Karolchik, D.; Armengol, L.; Bird, C.P.; de Bakker, P.I.; Kern, A.D.; Lopez-Bigas, N.; Martin, J.D.; Stranger, B.E.; Woodroffe, A.; Davydov, E.; Dimas, A.; Eyras, E.; Hallgrímsdóttir, I.B.; Huppert, J.; Zody, M.C.; Abecasis, G.R.; Estivill, X.; Bouffard, G.G.; Guan, X.; Hansen, N.F.; Idol, J.R.; Maduro, V.V.; Maskeri, B.; McDowell, J.C.; Park, M.; Thomas, P.J.; Young, A.C.; Blakesley, R.W.; Muzny, D.M.; Sodergren, E.; Wheeler, D.A.; Worley, K.C.; Jiang, H.; Weinstock, G.M.; Gibbs, R.A.; Graves, T.; Fulton, R.; Mardis, E.R.; Wilson, R.K.; Clamp, M.; Cuff, J.; Gnerre, S.; Jaffe, D.B.; Chang, J.L.; Lindblad-Toh, K.; Lander, E.S.; Koriabine, M.; Nefedov, M.; Osoegawa, K.; Yoshinaga, Y.; Zhu, B.; de Jong, P.J. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 2007, 447(7146), 799-816.

He, L.; Hannon, G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet., 2004, 5(7), 522-531.

Mercer, T.R.; Dinger, M.E.; Mattick, J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet., 2009, 10(3), 155-159.

Esteller, M. Non-coding RNAs in human disease. Nat. Rev. Genet., 2011, 12(12), 861-874.

January, C.T.; Wann, L.S.; Alpert, J.S.; Calkins, H.; Cigarroa, J.E.; Cleveland, J.C., Jr; Conti, J.B.; Ellinor, P.T.; Ezekowitz, M.D.; Field, M.E.; Murray, K.T.; Sacco, R.L.; Stevenson, W.G.; Tchou, P.J.; Tracy, C.M.; Yancy, C.W. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol., 2014, 64(21), e1-e76.

Wakili, R.; Voigt, N.; Kääb, S.; Dobrev, D.; Nattel, S. Recent advances in the molecular pathophysiology of atrial fibrillation. J. Clin. Invest., 2011, 121(8), 2955-2968.

Chinchilla, A.; Daimi, H.; Lozano-Velasco, E.; Dominguez, J.N.; Caballero, R.; Delpón, E.; Tamargo, J.; Cinca, J.; Hove-Madsen, L.; Aranega, A.E.; Franco, D. PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. Circ Cardiovasc Genet, 2011, 4(3), 269-279.

Christophersen, I.E.; Olesen, M.S.; Liang, B.; Andersen, M.N.; Larsen, A.P.; Nielsen, J.B.; Haunsø, S.; Olesen, S.P.; Tveit, A.; Svendsen, J.H.; Schmitt, N. Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation. Eur. Heart J., 2013, 34(20), 1517-1525.

Clauss, S.; Sinner, M.F.; Kääb, S.; Wakili, R. The role of microRNAs in antiarrhythmic therapy for atrial fibrillation. Arrhythm. Electrophysiol. Rev., 2015, 4(3), 146-155.

Tousoulis, D.; Kampoli, A.M.; Stefanadi, E.; Antoniades, C.; Siasos, G.; Papavassiliou, A.G.; Stefanadis, C. New biochemical markers in acute coronary syndromes. Curr. Med. Chem., 2008, 15(13), 1288-1296.

Shyu, A.B.; Wilkinson, M.F.; van Hoof, A. Messenger RNA regulation: To translate or to degrade. EMBO J., 2008, 27(3), 471-481.

Lee, Y.; Ahn, C.; Han, J.; Choi, H.; Kim, J.; Yim, J.; Lee, J.; Provost, P.; Rådmark, O.; Kim, S.; Kim, V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature, 2003, 425(6956), 415-419.

Gregory, R.I.; Yan, K.P.; Amuthan, G.; Chendrimada, T.; Doratotaj, B.; Cooch, N.; Shiekhattar, R. The Microprocessor complex mediates the genesis of microRNAs. Nature, 2004, 432(7014), 235-240.

Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.; Noteboom, J.; O’Briant, K.C.; Allen, A.; Lin, D.W.; Urban, N.; Drescher, C.W.; Knudsen, B.S.; Stirewalt, D.L.; Gentleman, R.; Vessella, R.L.; Nelson, P.S.; Martin, D.B.; Tewari, M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA, 2008, 105(30), 10513-10518.

Ambros, V. The functions of animal microRNAs. Nature, 2004, 431(7006), 350-355.

Chen, K.; Rajewsky, N. The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet., 2007, 8(2), 93-103.

Ouyang, Y.B.; Stary, C.M.; Yang, G.Y.; Giffard, R. microRNAs: Innovative targets for cerebral ischemia and stroke. Curr. Drug Targets, 2013, 14(1), 90-101.

Rodriguez, A.; Griffiths-Jones, S.; Ashurst, J.L.; Bradley, A. Identification of mammalian microRNA host genes and transcription units. Genome Res., 2004, 14(10A), 1902-1910.

MiRBase [database online]. June 2014. Available at: http://www.mirbase.org/index.shtml

Lewis, B.P.; Burge, C.B.; Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120(1), 15-20.

Friedman, R.C.; Farh, K.K.; Burge, C.B.; Bartel, D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 2009, 19(1), 92-105.

Pasquinelli, A.E. MicroRNAs and their targets: Recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet., 2012, 13(4), 271-282.

Lee, Y.; Kim, M.; Han, J.; Yeom, K.H.; Lee, S.; Baek, S.H.; Kim, V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J., 2004, 23(20), 4051-4060.

Borchert, G.M.; Lanier, W.; Davidson, B.L. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol., 2006, 13(12), 1097-1101.

Krol, J.; Loedige, I.; Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet., 2010, 11(9), 597-610.

Papageorgiou, N.; Tousoulis, D.; Androulakis, E. The role of microRNAs in cardiovascular disease. Curr. Med. Chem., 2012, 19, 2605.

Papageorgiou, N.; Tousoulis, D.; Androulakis, E.; Kontogeorgou, A.; Charakida, M.; Giolis, A.; Siama, K.; Trikas, A.; Briasoulis, A.; Pitsavos, C.; Stefanadis, C. The role of microRNAs in the initiation and progression of stable atheromatous plaque. Curr. Pharm. Des., 2013, 19(9), 1651-1657.

Papageorgiou, N.; Tousoulis, D.; Charakida, M.; Briasoulis, A.; Androulakis, E.; Tentolouris, C.; Siasos, G.; Stefanadis, C. Prognostic role of miRNAs in coronary artery disease. Curr. Top. Med. Chem., 2013, 13(13), 1540-1547.

Ruby, J.G.; Jan, C.H.; Bartel, D.P. Intronic microRNA precursors that bypass Drosha processing. Nature, 2007, 448(7149), 83-86.

Hutvágner, G.; Zamore, P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science, 2002, 297(5589), 2056-2060.

Valencia-Sanchez, M.A.; Liu, J.; Hannon, G.J.; Parker, R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev., 2006, 20(5), 515-524.

Huntzinger, E.; Izaurralde, E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet., 2011, 12(2), 99-110.

Zeng, Y.; Cullen, B.R. Sequence requirements for micro RNA processing and function in human cells. RNA, 2003, 9(1), 112-123.

Lim, L.P.; Lau, N.C.; Garrett-Engele, P.; Grimson, A.; Schelter, J.M.; Castle, J.; Bartel, D.P.; Linsley, P.S.; Johnson, J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 2005, 433(7027), 769-773.

Turchinovich, A.; Samatov, T.R.; Tonevitsky, A.G.; Burwinkel, B. Circulating miRNAs: cell-cell communication function? Front. Genet., 2013, 4, 119.

Turchinovich, A.; Weiz, L.; Langheinz, A.; Burwinkel, B. Characterization of extracellular circulating microRNA. Nucleic Acids Res., 2011, 39(16), 7223-7233.

Xu, J.; Zhao, J.; Evan, G.; Xiao, C.; Cheng, Y.; Xiao, J. Circulating microRNAs: Novel biomarkers for cardiovascular diseases. J. Mol. Med. (Berl.), 2012, 90(8), 865-875.

Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J.J.; Lötvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol., 2007, 9(6), 654-659.

Jaiswal, R.; Luk, F.; Gong, J.; Mathys, J.M.; Grau, G.E.; Bebawy, M. Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. Mol. Cancer, 2012, 11, 37.

Vardas, P.; Andrikopoulos, G.; Baroutsou, B. A greek prospective observational study of cardiovascular morbidity and mortality in patients with atrial fibrillation. Hellenic J. Cardiol., 2015, 56(6), 475-494.

Schotten, U.; Verheule, S.; Kirchhof, P.; Goette, A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol. Rev., 2011, 91(1), 265-325.

Kalifa, J.; Jalife, J.; Zaitsev, A.V.; Bagwe, S.; Warren, M.; Moreno, J.; Berenfeld, O.; Nattel, S. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation, 2003, 108(6), 668-671.

Wijffels, M.C.; Kirchhof, C.J.; Dorland, R.; Allessie, M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation, 1995, 92(7), 1954-1968.

van der Velden, H.M.; Ausma, J.; Rook, M.B.; Hellemons, A.J.; van Veen, T.A.; Allessie, M.A.; Jongsma, H.J. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc. Res., 2000, 46(3), 476-486.

Aimé-Sempé, C.; Folliguet, T.; Rücker-Martin, C.; Krajewska, M.; Krajewska, S.; Heimburger, M.; Aubier, M.; Mercadier, J.J.; Reed, J.C.; Hatem, S.N. Myocardial cell death in fibrillating and dilated human right atria. J. Am. Coll. Cardiol., 1999, 34(5), 1577-1586.

Atienza, F.; Almendral, J.; Moreno, J.; Vaidyanathan, R.; Talkachou, A.; Kalifa, J.; Arenal, A.; Villacastín, J.P.; Torrecilla, E.G.; Sánchez, A.; Ploutz-Snyder, R.; Jalife, J.; Berenfeld, O. Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism. Circulation, 2006, 114(23), 2434-2442.

Thum, T.; Gross, C.; Fiedler, J.; Fischer, T.; Kissler, S.; Bussen, M.; Galuppo, P.; Just, S.; Rottbauer, W.; Frantz, S.; Castoldi, M.; Soutschek, J.; Koteliansky, V.; Rosenwald, A.; Basson, M.A.; Licht, J.D.; Pena, J.T.; Rouhanifard, S.H.; Muckenthaler, M.U.; Tuschl, T.; Martin, G.R.; Bauersachs, J.; Engelhardt, S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 2008, 456(7224), 980-984.

Adam, O.; Löhfelm, B.; Thum, T.; Gupta, S.K.; Puhl, S.L.; Schäfers, H.J.; Böhm, M.; Laufs, U. Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res. Cardiol., 2012, 107(5), 278-284.

Cardin, S.; Guasch, E.; Luo, X.; Naud, P.; Le Quang, K.; Shi, Y.; Tardif, J.C.; Comtois, P.; Nattel, S. Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure. Circ Arrhythm Electrophysiol, 2012, 5(5), 1027-1035.

Chen, Y.; Wakili, R.; Xiao, J.; Wu, C.T.; Luo, X.; Clauss, S.; Dawson, K.; Qi, X.; Naud, P.; Shi, Y.F.; Tardif, J.C.; Kääb, S.; Dobrev, D.; Nattel, S. Detailed characterization of microRNA changes in a canine heart failure model: Relationship to arrhythmogenic structural remodeling. J. Mol. Cell. Cardiol., 2014, 77, 113-124.

Harada, M.; Luo, X.; Qi, X.Y.; Tadevosyan, A.; Maguy, A.; Ordog, B.; Ledoux, J.; Kato, T.; Naud, P.; Voigt, N.; Shi, Y.; Kamiya, K.; Murohara, T.; Kodama, I.; Tardif, J.C.; Schotten, U.; Van Wagoner, D.R.; Dobrev, D.; Nattel, S. Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation, 2012, 126(17), 2051-2064.

Dawson, K.; Wakili, R.; Ordög, B.; Clauss, S.; Chen, Y.; Iwasaki, Y.; Voigt, N.; Qi, X.Y.; Sinner, M.F.; Dobrev, D.; Kääb, S.; Nattel, S. MicroRNA29: A mechanistic contributor and potential biomarker in atrial fibrillation. Circulation, 2013. 127(14), 1466-1475, 1475e1-28.

Castoldi, G.; Di Gioia, C.R.; Bombardi, C.; Catalucci, D.; Corradi, B.; Gualazzi, M.G.; Leopizzi, M.; Mancini, M.; Zerbini, G.; Condorelli, G.; Stella, A. MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J. Cell. Physiol., 2012, 227(2), 850-856.

Li, H.; Li, S.; Yu, B.; Liu, S. Expression of miR-133 and miR-30 in chronic atrial fibrillation in canines. Mol. Med. Rep., 2012, 5(6), 1457-1460.

Shan, H.; Zhang, Y.; Lu, Y.; Zhang, Y.; Pan, Z.; Cai, B.; Wang, N.; Li, X.; Feng, T.; Hong, Y.; Yang, B. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc. Res., 2009, 83(3), 465-472.

Yang, B.; Lin, H.; Xiao, J.; Lu, Y.; Luo, X.; Li, B.; Zhang, Y.; Xu, C.; Bai, Y.; Wang, H.; Chen, G.; Wang, Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med., 2007, 13(4), 486-491.

Jia, X.; Zheng, S.; Xie, X.; Zhang, Y.; Wang, W.; Wang, Z.; Zhang, Y.; Wang, J.; Gao, M.; Hou, Y. MicroRNA-1 accelerates the shortening of atrial effective refractory period by regulating KCNE1 and KCNB2 expression: an atrial tachypacing rabbit model. PLoS One, 2013, 8(12), e85639.

Luo, X.; Pan, Z.; Shan, H.; Xiao, J.; Sun, X.; Wang, N.; Lin, H.; Xiao, L.; Maguy, A.; Qi, X.Y.; Li, Y.; Gao, X.; Dong, D.; Zhang, Y.; Bai, Y.; Ai, J.; Sun, L.; Lu, H.; Luo, X.Y.; Wang, Z.; Lu, Y.; Yang, B.; Nattel, S. MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J. Clin. Invest., 2013, 123(5), 1939-1951.

Chiang, D.Y.; Kongchan, N.; Beavers, D.L.; Alsina, K.M.; Voigt, N.; Neilson, J.R.; Jakob, H.; Martin, J.F.; Dobrev, D.; Wehrens, X.H.; Li, N. Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release. Circ Arrhythm Electrophysiol, 2014, 7(6), 1214-1222.

Callis, T.E.; Pandya, K.; Seok, H.Y.; Tang, R.H.; Tatsuguchi, M.; Huang, Z.P.; Chen, J.F.; Deng, Z.; Gunn, B.; Shumate, J.; Willis, M.S.; Selzman, C.H.; Wang, D.Z. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest., 2009, 119(9), 2772-2786.

Cañón, S.; Caballero, R.; Herraiz-Martínez, A.; Pérez-Hernández, M.; López, B.; Atienza, F.; Jalife, J.; Hove-Madsen, L.; Delpón, E.; Bernad, A. miR-208b upregulation interferes with calcium handling in HL-1 atrial myocytes: Implications in human chronic atrial fibrillation. J. Mol. Cell. Cardiol., 2016, 99, 162-173.

Lu, Y.; Zhang, Y.; Wang, N.; Pan, Z.; Gao, X.; Zhang, F.; Zhang, Y.; Shan, H.; Luo, X.; Bai, Y.; Sun, L.; Song, W.; Xu, C.; Wang, Z.; Yang, B. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation, 2010, 122(23), 2378-2387.

Harling, L.; Lambert, J.; Ashrafian, H.; Darzi, A.; Gooderham, N.J.; Athanasiou, T. Elevated serum microRNA 483-5p levels may predict patients at risk of post-operative atrial fibrillation. Eur. J. Cardiothorac. Surg., 2017, 51(1), 73-78.

Morishima, M.; Iwata, E.; Nakada, C.; Tsukamoto, Y.; Takanari, H.; Miyamoto, S.; Moriyama, M.; Ono, K. Atrial fibrillation-mediated upregulation of miR-30d regulates myocardial electrical remodeling of the G-protein-gated K(+) channel, IK.ACh. Circ. J., 2016, 80(6), 1346-1355.

Karakikes, I.; Chaanine, A.H.; Kang, S.; Mukete, B.N.; Jeong, D.; Zhang, S.; Hajjar, R.J.; Lebeche, D. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J. Am. Heart Assoc., 2013, 2(2), e000078.

Caroli, A.; Cardillo, M.T.; Galea, R.; Biasucci, L.M. Potential therapeutic role of microRNAs in ischemic heart disease. J. Cardiol., 2013, 61(5), 315-320.

Bernardo, B.C.; Ooi, J.Y.; Matsumoto, A.; Tham, Y.K.; Singla, S.; Kiriazis, H.; Patterson, N.L.; Sadoshima, J.; Obad, S.; Lin, R.C.; McMullen, J.R. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: Identification of sex-, disease- and treatment-regulated miRNAs. J. Physiol., 2016, 594(20), 5959-5974.

Wang, T.; Wang, B. Identification of microRNA-mRNA interactions in atrial fibrillation using microarray expression profiles and bioinformatics analysis. Mol. Med. Rep., 2016, 13(6), 4535-4540.